Hall, MD, professor and chair of radiation oncology at the Medical College of Wisconsin and medical director of Froedtert ...

Intensity-modulated proton therapy (IMPT) allows radiation oncologists to limit the dose to organs surrounding the prostate. That property may be particularly relevant for patients with prostate ...

Patient enrollment of the phase 3 IDeate-Lung02 trial assessing I-DXd vs chemotherapy in relapsed ES-SCLC will continue ...

Poster presentations at IMS 2026 highlighted the use of venetoclax, daratumumab, and different combination regimens across ...

Resection combined with cesium-131 collagen tile-based radiation therapy (TBRT; GammaTile) significantly improved time to ...

At 8 years, SBRT and radical prostatectomy had similar disease control in the PACE-A trial, with less urinary incontinence ...

William A. Hall, MD, explains how fewer visits, no concurrent chemotherapy, and adaptive MRI guidance may have preserved quality of life with SBRT.

Hall, MD, discussed how preoperative SBRT may serve as a platform for novel systemic therapies in pancreatic adenocarcinoma. In an interview with CancerNetwork® at the 2026 American Society for ...

Ethan B. Ludmir, MD, explains why advanced radiation techniques like protons fit nonoperative cholangiocarcinoma better than ...

Ayal Aizer, MD, MHS, discusses patients for whom single-fraction SRS may remain reasonable after brain metastasis resection.

Elizabeth Thompson, MD, discusses pediatric cancer, proton therapy, and her work as a peer reviewer for CURiE. In an ...

In a phase 1 first-in-human trial, BMS-986453 showed a favorable safety profile and high response rates in ...